{"id":526892,"date":"2026-07-01T02:47:08","date_gmt":"2026-07-01T02:47:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/526892\/"},"modified":"2026-07-01T02:47:08","modified_gmt":"2026-07-01T02:47:08","slug":"infectious-disease-advisor-single-tablet-bic-len-noninferior-to-bic-ftc-taf-in-suppressed-hiv","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/526892\/","title":{"rendered":"Infectious Disease Advisor: Single-tablet BIC\/LEN noninferior to BIC\/FTC\/TAF in suppressed HIV"},"content":{"rendered":"<p>Infectious Disease Advisor news story<\/p>\n<p>Results of a phase 3, noninferiority trial support bictegravir plus lenacapavir (BIC\/LEN) as an effective single-tablet antiretroviral therapy (ART) for virologically suppressed patients with HIV-1 infection. These study findings were published in The Lancet HIV.<\/p>\n<p class=\"wp-block-paragraph\">Reducing the complexity of ART with single-tablet formulations has improved treatment adherence, clinical outcomes, quality of life, and patient satisfaction. The trial ARTISTRY-1 found that switching to single-tablet BIC\/LEN was noninferior to remaining on complex ART.<\/p>\n<p class=\"wp-block-paragraph\">Researchers conducted a double-blind, randomized, controlled, phase 3, noninferiority trial (ARTISTRY-2; ClinicalTrials.gov Identifier: <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06333808\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">NCT06333808<\/a>) to assess the noninferiority of single-tablet BIC\/LEN relative to single-tablet bictegravir plus emtricitabine and tenofovir alafenamide (BIC\/FTC\/TAF). People with HIV (PWH; N=574) who had viral suppression on single-tablet BIC\/FTC\/TAF were recruited in 14 countries in 2024. The participants were randomly assigned 2:1 to either switch to 75-50 mg BIC\/LEN or continue using 50-200-25 mg BIC\/FTC\/TAF for 48 weeks. The primary outcome was the proportion of individuals with HIV-1 RNA of at least 50 copies\/mL at week 48. Noninferiority was defined as a margin of 4%.<\/p>\n<p>Read the full news story <a href=\"https:\/\/www.infectiousdiseaseadvisor.com\/news\/single-tablet-bic-len-noninferior-to-bic-ftc-taf-in-suppressed-hiv\/\" target=\"_blank\" rel=\"noopener nofollow\">here<\/a>.<\/p>\n<p>\/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month\/<\/p>\n<p>\u00a0<\/p>\n<p>Source : <a href=\"https:\/\/www.infectiousdiseaseadvisor.com\/news\/single-tablet-bic-len-noninferior-to-bic-ftc-taf-in-suppressed-hiv\/\" target=\"_blank\" rel=\"nofollow noopener\">Infectious Disease Advisor<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Infectious Disease Advisor news story Results of a phase 3, noninferiority trial support bictegravir plus lenacapavir (BIC\/LEN) as&hellip;\n","protected":false},"author":2,"featured_media":43430,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-526892","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/526892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=526892"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/526892\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/43430"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=526892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=526892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=526892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}